Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTYPTryptamine TherapeuticsAU$44.67mn/an/a
au flag iconIDTIDT AustraliaAU$42.98mn/an/a
au flag iconADOAnteotechAU$37.87mn/an/a
au flag iconPTXPrescient TherapeuticsAU$32.21mn/an/a
au flag iconNTINeurotech InternationalAU$30.22mn/an/a
au flag iconILAIsland PharmaceuticalsAU$29.96mn/an/a
au flag iconRHYRhythm BiosciencesAU$23.82mn/an/a
au flag iconATXAmplia TherapeuticsAU$22.54mn/an/a
au flag iconNOXNoxopharmAU$21.33mn/an/a
au flag iconCC5Clever Culture SystemsAU$21.12mn/an/a
au flag iconAVEAvecho BiotechnologyAU$19.02mn/an/a
au flag iconKZAKazia TherapeuticsAU$18.24mn/an/a
au flag iconTRPTissue RepairAU$16.63mn/an/a
au flag iconBTCBTC HealthAU$16.53m4n/a
au flag iconEMDEmyriaAU$16.12mn/an/a
au flag iconBNOBionomicsAU$14.69mn/an/a
au flag iconPERPercheron TherapeuticsAU$11.96mn/an/a
au flag iconBPHBPH EnergyAU$10.96m0.85n/a
au flag iconIVXInvionAU$9.08mn/an/a
au flag icon1AIAlgorae PharmaceuticalsAU$8.44mn/an/a